WO2008005333A3 - Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females - Google Patents

Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females Download PDF

Info

Publication number
WO2008005333A3
WO2008005333A3 PCT/US2007/015129 US2007015129W WO2008005333A3 WO 2008005333 A3 WO2008005333 A3 WO 2008005333A3 US 2007015129 W US2007015129 W US 2007015129W WO 2008005333 A3 WO2008005333 A3 WO 2008005333A3
Authority
WO
WIPO (PCT)
Prior art keywords
extended cycle
osteopenia
related conditions
treatment
contraceptive regimens
Prior art date
Application number
PCT/US2007/015129
Other languages
French (fr)
Other versions
WO2008005333A2 (en
Inventor
Kathleen Reape
Original Assignee
Duramed Pharmaceuticals Inc
Kathleen Reape
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc, Kathleen Reape filed Critical Duramed Pharmaceuticals Inc
Publication of WO2008005333A2 publication Critical patent/WO2008005333A2/en
Publication of WO2008005333A3 publication Critical patent/WO2008005333A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of treating or preventing osteopenia and/or related conditions due to low estrogen levels in adolescent females.
PCT/US2007/015129 2006-06-30 2007-06-29 Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females WO2008005333A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81753106P 2006-06-30 2006-06-30
US60/817,531 2006-06-30

Publications (2)

Publication Number Publication Date
WO2008005333A2 WO2008005333A2 (en) 2008-01-10
WO2008005333A3 true WO2008005333A3 (en) 2008-08-28

Family

ID=38895132

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/015129 WO2008005333A2 (en) 2006-06-30 2007-06-29 Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females

Country Status (1)

Country Link
WO (1) WO2008005333A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1028185B1 (en) 2020-04-03 2021-11-04 Flooring Ind Ltd Sarl Panel

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220152A1 (en) * 2003-05-02 2004-11-04 Ben-Maimon Carole S. Methods of hormonal treatment utilizing extended cycle contraceptive regimens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220152A1 (en) * 2003-05-02 2004-11-04 Ben-Maimon Carole S. Methods of hormonal treatment utilizing extended cycle contraceptive regimens

Also Published As

Publication number Publication date
WO2008005333A2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
MX2009004616A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens.
IL264796B (en) 6,23-substituted bile acid derivatives, pharmaceutically acceptable compositions and compounds for use in a method of treating or preventing a disease
WO2008079245A3 (en) Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
WO2004098517A8 (en) Methods of hormonal treatment utilizing extended cycle contraceptive regimens
HK1166263A1 (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2010081032A3 (en) Steroidal compositions
WO2006042021A3 (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
WO2011123719A3 (en) Use of faah inhibitors for treating abdominal, visceral and pelvic pain
IL195472A0 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
CL2013001136A1 (en) A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent.
MX347237B (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction.
WO2009079451A3 (en) Compositions and methods of promoting wound healing
HK1137352A1 (en) Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent
WO2010091299A3 (en) Combination of a 17 alpha-hydr0xylase/c17, 20-lyase inhibitor with an additional therapeutic agent
WO2007100561A3 (en) Use of dha and ara in the preparation of a composition for preventing or treating obesity
NZ577390A (en) Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2007001395A3 (en) Prevention and treatment of influenza with glutamine antagonist agents
TNSN08506A1 (en) Substituted carboxamides
EP2099464A4 (en) Local administration of gallium compositions to treat pain
WO2008077027A3 (en) Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders
WO2008005333A3 (en) Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females
NZ594486A (en) Narcotic emulsion opioid analgesic formulations for treatment of cancer pain

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07810047

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07810047

Country of ref document: EP

Kind code of ref document: A2